Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adrenal Cortex Neoplasms × Osilodrostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cushing Syndrome 1 Adrenal Cortex Neoplasms 1 Acth-Independent Macronodular Adrenal Hyperplasia 1 ACTH Syndrome, Ectopic 1

Interventions

relacorilant 2 cabozantinib 2 tariquidar 1 pembrolizumab 1 Specimen Handling 1 Pharmacogenomic Variants 1 Pharmacogenomic Testing 1 Osilodrostat 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Gefitinib 1 Floxuridine 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02468193 2020-05-06

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Novartis

Phase 2 Completed

9 enrolled 22 charts

Acth-Independent Macronodular Adrenal Hyperplasia, ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡